check_circleStudy Completed

Sunscreening Agents

Bayer Identifier:

18751

ClinicalTrials.gov Identifier:

NCT02739802

EudraCT Number:

Not Available

EU CT Number:

Not Available
18751-Sun Protection Factor Assay.

Trial purpose

To evaluate the Sun Protection Factor (SPF) efficacy on human skin.

Key Participants Requirements

Sex

Both

Age

18 - 70 Years
  • - Fitzpatrick Skin Type l, ll and/or lll for UVB testing. Fitzpatrick Skin Type ll, lll and/or lV for UVA testing. - Male or female - Aged between 18-70 years old. - Good health - Signed and dated Informed Consent Form - Signed and dated Health Insurance Portability and Accountability Authorization (HIPAA) Form - An unambiguous MED or MPPD (Minimal Persistent Pigment Darkening Dose)
  • - Subjects on test at any other research laboratory or clinic. - Known allergy or sensitivity to sunscreens, cosmetics and toiletries, topical drugs and/or ultraviolet light. - PRe-existing dermatologic conditions which have been diagnoses by a medical professional (e.g. psoriasis, eczema, etc.) which would interfere with this study. - Pre-existing other medical conditions (e.g. adult asthma. diabetes). - Treatment with antihistamines or corticosteroids within one week prior to initiation of the test. - Treatment with antibiotics within two weeks prior to initiation of the test - Chronic medication which could affect the results of the study. - Known pregnant or nursing women.

Trial summary

Enrollment Goal
10
Trial Dates
March 2016 - March 2016
Phase
N/A
Could I Receive a placebo
No
Products
BAY987517
Accepts Healthy Volunteer
Yes

Where to participate

StatusInstitutionLocation
Completed
Union, 07083, United States

Primary Outcome

  • Minimal Erythema Dose(MED)
    date_rangeTime Frame:
    Up to 15 minutes
    enhanced_encryption
    Safety Issue:
    No
  • Minimal Persistent Pigment Darkening Dose (MPPD)
    date_rangeTime Frame:
    Up to 15 minutes
    enhanced_encryption
    Safety Issue:
    No

Trial design

Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay Minimal Persistent Pigment-Darkening Dose
Trial Type
Interventional
Intervention Type
Drug
Trial Purpose
Treatment
Allocation
N/A
Blinding
Open Label
Assignment
Single Group Assignment
Trial Arms
1

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to Bayer products.